ABSTRACT
OBJECTIVE: The present study examined the factor structure of the Race-Based Traumatic Stress Symptom Scale (RBTSSS) in a sample of Asian American adults. METHOD: The sample (n = 403) comprised 78% women, ages 18-72 years, who were administered the RBTSSS in a survey. A first-order and second-order confirmatory factor analysis (CFA) were conducted. RESULTS: The RBTSSS demonstrated good internal consistency in the present study, Cronbach's αs = .78-.94. The first-order CFA revealed mixed model fit indices, χ²(1,253) = 3,431.52, p < .001, root mean square error of approximation (RMSEA) = .066, comparative fit index (CFI) = .875, Tucker-Lewis index (TLI) = .868. The second-order CFA revealed similar mixed findings, χ²(1,267) = 3,559.93, p < .001, RMSEA = .067, CFI = .869, TLI = .863. CONCLUSIONS: Findings demonstrated mixed support for the factor structure of the RBTSSS in a sample of Asian American adults. Future research may consider additional testing of the RBTSSS in Asian Americans and further exploring the construct of racial trauma in Asian Americans. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
ABSTRACT
With the onset of the global coronavirus disease 2019 pandemic in early 2020, it became apparent that routine administration of the ABR Qualifying and Certifying Exams would be disrupted. Initial intent for postponement was later altered to a recognition that replacement of the existing delivery methodologies was essential. Herein, the authors describe the conceptualization, development, administration, and future implications of the new remote examination delivery platforms.
Subject(s)
COVID-19 , Internship and Residency , Radiation Oncology , Certification , Educational Measurement , Forecasting , Humans , Radiation Oncology/education , Specialty Boards , United StatesABSTRACT
The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.